Metabolic side effects of antipsychotic drug treatment – pharmacological mechanisms
- 31 January 2010
- journal article
- review article
- Published by Elsevier BV in Pharmacology & Therapeutics
- Vol. 125 (1), 169-179
- https://doi.org/10.1016/j.pharmthera.2009.10.010
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Efficacy and safety of oral paliperidone extended-release tablets in the treatment of acute schizophrenia: pooled data from three 52-week open-label studiesInternational Clinical Psychopharmacology, 2008
- Effect of Antipsychotics on Peptides Involved in Energy Balance in Drug-Naive Psychotic Patients After 1 Year of TreatmentJournal of Clinical Psychopharmacology, 2008
- Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trialThe Lancet, 2008
- Impact of atypical antipsychotic therapy on leptin, ghrelin, and adiponectinSchizophrenia Research, 2008
- Metabolic syndrome and insulin resistance in schizophrenia patients receiving antipsychotics genotyped for the methylenetetrahydrofolate reductase (MTHFR) 677C/T and 1298A/C variantsSchizophrenia Research, 2008
- Body Mass Index as a Screening Test for Metabolic Syndrome in Schizophrenia and Schizoaffective DisordersAustralasian Psychiatry, 2007
- Serotonin 2C Receptor Agonists Improve Type 2 Diabetes via Melanocortin-4 Receptor Signaling PathwaysCell Metabolism, 2007
- Antipsychotic drug-induced weight gain mediated by histamine H1receptor-linked activation of hypothalamic AMP-kinaseProceedings of the National Academy of Sciences of the United States of America, 2007
- The hypothalamus and the control of energy homeostasis: Different circuits, different purposesPhysiology & Behavior, 2001
- Binding of antipsychotic drugs to human brain receptors: Focus on newer generation compoundsLife Sciences, 2000